The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults
Open accessAbstract
BACKGROUND: Stroke is a leading cause of death and disability worldwide. Despite considerable improvements in diagnosis and treatment, little is known about the short-term and long-term prognosis after a first stroke in low-income and middle-income countries, including China. We aimed to assess the short-term and long-term risk of recurrent stroke and mortality after a first stroke for each of the major pathological stroke types. METHODS: This population-based cohort study included adults aged 35-74 years without disability who were recruited to the China Kadoorie Biobank (CKB). A baseline survey was conducted in ten geographical areas (five urban, five rural) in China, and participants had clinical measurements recorded. Participants were followed up by monitoring death registries and by electronic linkage to health registries and health insurance claims databases, with follow-up until Jan 1, 2017. Participants were excluded from analyses if they had a previous history of stroke, transient ischaemic attack, or ischaemic heart disease at baseline. All incidences of fatal and non-fatal stroke during the study period were recorded by type (ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and unspecified type). Primary outcome measures were 28-day mortality, recurrent stroke, major vascular events (recurrent stroke, myocardial infarction, or vascular death), vascular mortality, and all-cause mortality. FINDINGS: Of 512 715 individuals in the CKB, 489 586 participants without previous ischaemic heart disease and stroke at recruitment were included, of whom 45 732 (42 073 [92%] confirmed by brain imaging) had a stroke during the study period. The mean age was 59·3 years (SD 9·8) for participants who had a stroke (54% women) and 50·8 years (10·3) for participants with no stroke (60% women). 36 588 (80%) of the incident cases of stroke were ischaemic stroke, 7440 (16%) were intracerebral haemorrhage, 702 (2%) were subarachnoid haemorrhage, and 1002 (2%) were an unspecified stroke type. 28-day mortality was 3% (95% CI 3-4) for ischaemic stroke, 47% (46-48)for intracerebral haemorrhage, 19% (17-22; 52% for rural areas and 32% for urban areas) subarachnoid haemorrhage, and 24% (22-27) for unspecified stroke. Among participants who survived stroke at 28 days, 41% (41-42) had recurrent stroke at 5 years (ischaemic stroke 41% [41-42], intracerebral haemorrhage 44% [42-46], subarachnoid haemorrhage 22% [18-27], unspecified stroke type 40% [35-44]) and mortality at 5 years was 17% ([17-18] ischaemic stroke 16% [15-16], intracerebral haemorrhage 28% [26-29], subarachnoid haemorrhage 16% [12-20], unspecified stroke type 15% [12-19]). After a first ischaemic stroke, 91% of recurrent strokes were also ischaemic stroke; after an intracerebral haemorrhage, 56% of recurrent strokes were intracerebral haemorrhage, and 41% of recurrent strokes were ischaemic stroke. INTERPRETATION: After a first stroke, the risk of recurrence or death within 5 years was high among this population of Chinese adults. Urgent improvements to secondary prevention of stroke in China are needed to reduce these risks. FUNDING: Wellcome Trust, Medical Research Council, British Heart Foundation, Cancer Research UK, Kadoorie Charitable Foundation, Chinese Ministry of Science and Technology, National Natural Science Foundation of China. COPYRIGHT: © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives.
Greebe, P., Bromberg, J. E., Rinkel, G. J., Algra, A., & van Gijn, J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.3.273 · Cited by 4,139
Hemphill, J. C., Greenberg, S. M., Anderson, C. S., Becker, K., Bendok, B. R., Cushman, M., Fung, G. L., Goldstein, J. N., Macdonald, R. L., Mitchell, P. H., et al. (2015) · Stroke · doi:10.1161/str.0000000000000069 · Cited by 3,994
van Asch, C. J., Luitse, M. J., Rinkel, G. J., van der Tweel, I., Algra, A., & Klijn, C. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70340-0 · Cited by 2,658
O'Donnell, M. J., Chin, S. L., Rangarajan, S., Xavier, D., Liu, L., Zhang, H., Rao-Melacini, P., Zhang, X., Pais, P., Agapay, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30506-2 · Cited by 2,296
Self-citationWang, W., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., Wang, L., Jiang, Y., Li, Y., Wang, Y., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025250 · Cited by 1,977
Self-citationStroke in China: advances and challenges in epidemiology, prevention, and management
Wu, S., Wu, B., Liu, M., Chen, Z., Wang, W., Anderson, C. S., Sandercock, P., Wang, Y., Huang, Y., Cui, L., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30500-3 · Cited by 1,589
Self-citationNieuwkamp, D. J., Setz, L. E., Algra, A., Linn, F. H., de Rooij, N. K., & Rinkel, G. J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70126-7 · Cited by 1,507
Zhou, M., Wang, H., Zhu, J., Chen, W., Wang, L., Liu, S., Li, Y., Wang, L., Liu, Y., Yin, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00551-6 · Cited by 1,464
Self-citationUpdate on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
Feigin, V. L., Krishnamurthi, R. V., Parmar, P., Norrving, B., Mensah, G. A., Bennett, D. A., Barker-Collo, S., Moran, A. E., Sacco, R. L., Truelsen, T., et al. (2015) · Neuroepidemiology · doi:10.1159/000441085 · Cited by 1,309
Self-citationRothwell, P., Coull, A., Giles, M., Howard, S., Silver, L., Bull, L., Gutnikov, S., Edwards, P., Mant, D., Sackley, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16405-2 · Cited by 1,094
Cited by
Wolsink, A., Cliteur, M. P., van Asch, C. J., Boogaarts, H. D., Dammers, R., Hannink, G., Schreuder, F. H. B. M., & Klijn, C. J. M. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101180 · Cited by 52
Liang, J., Luo, C., Ke, S., & Tung, T.-H. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102340 · Cited by 14
Ma, R., Qiao, M., Zhou, Y., Sun, W., Lv, Y., Zhou, X., Wang, Y., Wu, X., & Yu, R. (2026) · Journal of Clinical Nursing · doi:10.1111/jocn.17820 · Cited by 3
Self-citation
Metadata
- Authors
- Chen, Y., Wright, N., Guo, Y., Turnbull, I., Kartsonaki, C., Yang, L., Bian, Z., Pei, P., Pan, D., Zhang, Y., Qin, H., Wang, Y., Lv, J., Liu, M., Hao, Z., Wang, Y., Yu, C., Peto, R., Collins, R., Li, L., Clarke, R., Chen, Z., Chen, Y., Wright, N., Guo, Y., Turnbull, I., Kartsonaki, C., Yang, L., Bian, Z., Pei, P., Pan, D., Zhang, Y., Qin, H., Wang, Y., Lv, J., Liu, M., Hao, Z., Wang, Y., Yu, C., Peto, R., Collins, R., Li, L., Clarke, R., Chen, Z., Chen, J., Walters, R., Avery, D., Bennett, D., Boxall, R., Bragg, F., Chang, Y., Du, H., Gilbert, S., Hacker, A., Holmes, M., Kerosi, R., Lancaster, G., Lin, K., McDonnell, J., Millwood, I., Nie, Q., Ryder, P., Sansome, S., Schmidt, D., Sohoni, R., Wang, J., Wang, L., Yang, X., Han, X., Hou, C., Jing, B., Liu, C., Pang, Z., Gao, R., Li, S., Wang, S., Liu, Y., Du, R., Zang, Y., Cheng, L., Tian, X., Zhang, H., Zhai, Y., Ning, F., Sun, X., Li, F., Lv, S., Wang, J., Hou, W., Zeng, M., Jiang, G., Zhou, X., Yang, L., He, H., Yu, B., Li, Y., Xu, Q., Kang, Q., Guo, Z., Wang, D., Hu, X., Wang, H., Chen, J., Fu, Y., Fu, Z., Wang, X., Weng, M., Guo, Z., Wu, S., Li, Y., Li, H., Fu, Z., Wu, M., Zhou, Y., Zhou, J., Tao, R., Yang, J., Su, J., Liu, F., Zhang, J., Hu, Y., Lu, Y., Ma, L., Tang, A., Zhang, S., Jin, J., Liu, J., Tang, Z., Chen, N., Huang, Y., Li, M., Meng, J., Pan, R., Jiang, Q., Lan, J., Liu, Y., Wei, L., Chen, N., Wang, P., Meng, F., Qin, Y., Wang, S., Wu, X., Zhang, N., Chen, X., Zhou, W., Luo, G., Li, J., Zhong, X., Liu, J., Sun, Q., Ge, P., Ren, X., Dong, C., Zhang, H., Mao, E., Wang, X., Wang, T., Zhang, X., Zhang, D., Zhou, G., Feng, S., Chang, L., Fan, L., Gao, Y., He, T., Sun, H., He, P., Hu, C., Zhang, X., Wu, H., Yu, M., Hu, R., Wang, H., Qian, Y., Wang, C., Xie, K., Chen, L., Fu, Z., Xu, Q., Xu, X., Zhang, H., Long, H., Li, X., Zhang, L., & Qiu, Z.
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 8
- Issue
- 4
- Pages
- e580-e590
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W3010733248
- Cited by
- 329
- References
- 39
- FWCI
- 22.42
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (81390544, 81390540, 81390541)
- Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 088158/Z/09/Z, 104085/Z/14/Z)
- Kadoorie Charitable Foundation
- National Key Research and Development Program of China (0900504, 0900501, 2016YFC 0900500, 1303904)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. https://app.cochat.ai/papers/10.1016/s2214-109x(20)30069-3
- The paper
- Chen, Y., Wright, N., Guo, Y., Turnbull, I., Kartsonaki, C., Yang, L., Bian, Z., Pei, P., Pan, D., Zhang, Y., Qin, H., Wang, Y., Lv, J., Liu, M., Hao, Z., Wang, Y., Yu, C., Peto, R., Collins, R., . . . Qiu, Z. (2020). Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(20)30069-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.